Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2004-03-29
2009-02-17
Parkin, Jeffrey S. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C435S236000
Reexamination Certificate
active
07491400
ABSTRACT:
A therapeutic suspension for the treatment of human immunodeficiency virus type I (HIV-1) infection in humans using isolated and purified HIV-1 nef-deficient viral particles having a nef-deletion between the endonuclease cleavage sites Nco I and Xho I.
REFERENCES:
patent: 5851813 (1998-12-01), Desrosiers
Letvin, N. L., and B. D. Walker, 2003, “Immunopathogenesis and immunotherapy in AIDS virus infections”, Nat. Med. 9(7):861-866.
Piguet, V., and D. Trono, 2001, “Living in oblivion:HIV immune evasion”, Sem. Immunol. 13:51-57.
Mooji, P., et al., 2002, “Rational development of prophylactic HIV vaccines based on structural and regulatory proteins”, Vaccine 20:304-321.
Barouch, D. H., and N. L. Letvin, 2002, “Viral evolution and challenges in the development of HIV vaccines”, Vaccine 20:A66-A68.
Altman, J. D., and M. B. Feinberg, 2004, “HIV escape:there and back again”, Nat. Med. 10(3):229-230.
Gallo, R. C., 2005, “The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years”, Lancet 366:1894-1898.
Betts, M. R., et al., 2005, “Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection”, Proc. Natl. Acad. Sci. USA 102(12):4512-4517.
Johnson, R. P., 1999, Live attenuated AIDS vaccines: Hazards and hopes, Nat. Med. 5(2):154-155.
Baba, T. W., et al., 1999, Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques, Nat. Med. 5(2): 194-203.
Hofmann-Lehmann, R. et al., 2003, Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation, AIDS 17:157-166.
Bielen, Jr. Theodore J.
Parkin Jeffrey S.
Swiss Pacific Group, Ltd
LandOfFree
Pharmaceutical compositions comprising attenuated HIV-1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising attenuated HIV-1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising attenuated HIV-1... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4110196